Inhibikase Amends Certificate of Incorporation to Limit Fiduciary Liability

Inhibikase Therapeutics filed an amendment to its charter to eliminate personal monetary liability for directors and officers for breaches of fiduciary duty. This corporate governance update is aimed at protecting management from shareholder lawsuits under Delaware law.